/

Empresas

Ce

No verificado

Cellares

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMercado laboralSalud

20 Comunicados de prensa

Ver todos los comunicados de prensa

18/02/2026

Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors

Fuente

Editor

1.00

0

03/02/2026

Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies

Fuente

Editor

1.00

0

28/01/2026

Cellares Raises $257 Million Series D Led by BlackRock and Eclipse to Industrialize Global Cell Therapy Manufacturing with Breakthrough Automation

Fuente

Editor

1.00

0

12/01/2026

Mercado laboral

Industria

Biotecnología

Sanidad

Salud

Farmacéutica

Ciencia

Cellares amplia la rete globale di Smart Factory con una sede centrale europea nei Paesi Bassi

Fuente

Editor

1.00

0

12/01/2026

Industria

Salud

Biotecnología

Medicina - Varios

Ciencia

Farmacéutica

IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms

Fuente

Editor

1.00

0

12/01/2026

Mercado laboral

Industria

Biotecnología

Sanidad

Salud

Farmacéutica

Ciencia

Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands

Fuente

Editor

1.00

0

08/01/2026

Ciencia

Sanidad

Farmacéutica

Oncología

Industria

Biotecnología

Salud

Mercado laboral

Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy

Fuente

Editor

1.00

0

01/12/2025

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO

Fuente

Editor

1.00

0

22/09/2025

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Fuente

Editor

1.00

0

17/09/2025

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0